glp-1 overview Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Safety and Tolerability of Glucagon-Like

Semaglutide shows slower but more sustainable resultsstudies show consistent reduction over several months, with long-term maintenance possible through ongoing treatment and support

2024 clinical practice guideline for the evaluation and management of chronic kidney disease

While this study was observational i.e., participants were not randomly assigned to one medication or the other the study used a complex weighting strategy to control for many variables that might influence the relationship between mediation prescription and substance use outcomes

Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids